Fabio Efficace
- Oncology top 0.5%
- Cancer survivorship and care 56
- Hematology top 1%
- Acute Myeloid Leukemia Research 29
- Chronic Myeloid Leukemia Treatments 26
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 17
- Geriatrics and Gerontology top 2%
-
- Childhood Cancer Survivors' Quality of Life 37
-
- Health Systems, Economic Evaluations, Quality of Life 43
-
- Palliative Care and End-of-Life Issues 26
- Acute Lymphoblastic Leukemia research 19
- Co-authors
- Andrew BottomleyCarolyn GotayCorneel CoensCrissy T. KawamotoNeil K. AaronsonFrancesco CottoneJane BlazebyMarco Vignetti
- Cited by
- OncologyHematologyGenetics
- Journals
- Journal of Clinical Oncology (18 papers)European Journal of Cancer (14 papers)Blood (12 papers)
- Partner nations
- ItalyUnited KingdomNetherlands
In The Last Decade
Fabio Efficace
208 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 3.1k
- Hematology 975
- Genetics 881
- Geriatrics and Gerontology 219
- Pediatrics, Perinatology and Child Health 1.0k
Countries citing papers authored by Fabio Efficace
This map shows the geographic impact of Fabio Efficace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Efficace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Efficace more than expected).
Fields of papers citing papers by Fabio Efficace
This network shows the impact of papers produced by Fabio Efficace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Efficace. The network helps show where Fabio Efficace may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fabio Efficace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 13 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 20 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 14 | |
| 11 | Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS) | 2020 | 0 |
| 12 | 2020 | 13 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 16 | |
| 16 | 2018 | 7 | |
| 17 | 2016 | 16 | |
| 18 | Development of an EORTC module for the assessment of cancer related fatigue (EORTC FAR-15): Phase III results. | 2007 | 1 |
| 19 | Non-small cell lung cancer and health-related quality of life (HRQOL): Is baseline HRQOL of prognostic value for survival? | 2005 | 1 |
| 20 | 2003 | 1 |
About Fabio Efficace
Fabio Efficace is a scholar working on Hematology, Oncology and Genetics, having authored 215 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer survivorship and care (56 papers), Health Systems, Economic Evaluations, Quality of Life (43 papers), Childhood Cancer Survivors' Quality of Life (37 papers), Acute Myeloid Leukemia Research (29 papers), Palliative Care and End-of-Life Issues (26 papers), Chronic Myeloid Leukemia Treatments (26 papers), Acute Lymphoblastic Leukemia research (19 papers) and Chronic Lymphocytic Leukemia Research (17 papers). The work is most often cited by research in Oncology (3.1k citations), Hematology (975 citations) and Genetics (881 citations). Fabio Efficace has collaborated with scholars based in Italy, United Kingdom and Netherlands. Frequent co-authors include Andrew Bottomley, Carolyn Gotay, Corneel Coens, Crissy T. Kawamoto, Neil K. Aaronson, Francesco Cottone, Jane Blazeby, Marco Vignetti, Franco Mandelli and Giovanni Caocci. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Blood, Annals of Hematology and Quality of Life Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.